Willner & Heller’s GSK GSK Stock Holding History

Willner & Heller’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,595	Closed	-$556K	–	157
2024 Q3	$556K	Sell	13,595 -18	-0.1%	-$736	0.5%	60
2024 Q2	$524K	Sell	13,613 -360	-3%	-$15.1K	0.5%	63
2024 Q1	$599K	Hold	13,973	–	–	0.6%	54
2023 Q4	$518K	Buy	+13,973	New	+$502K	0.58%	56
2022 Q4	$606K	Sell	17,242 -1,797	-9%	-$59.9K	0.86%	39
2022 Q3	$560K	Buy	19,039 +13,102	+221%	+$497K	0.9%	39
2022 Q2	$323K	Buy	5,937 +1,920	+48%	+$106K	0.5%	72
2022 Q1	$221K	Buy	+4,017	New	+$218K	0.27%	129

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Willner & Heller's GSK Position: Q4 2024 in Review

Willner & Heller sold out of GSK (GSK) in Q4 2024, closing a stake of 13,595 shares — an estimated $556K sold.

Willner & Heller first reported a position in GSK in Q1 2022 and held it in 8 quarters. The position peaked at $606K in Q4 2022. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Willner & Heller reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Willner & Heller sold 13,595 GSK shares in Q4 2024, an estimated $556K.
Willner & Heller first reported a position in GSK in Q1 2022 and held it in 8 quarters.
Willner & Heller's GSK position peaked at $606K in Q4 2022.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Willner & Heller's 13F filing for Q4 2024, filed 16 Jan 2025.